Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2020-07-10 10:39 am Purchase | 13G | MERSANA THERAPEUTICS INC MRSN | BlackRock Inc. BLK | 7,137,740 10.7% | 4,672,421 (+189.53%) | View |
| 2020-04-24 2:17 pm Sale | 13D | MERSANA THERAPEUTICS INC MRSN | New Enterprise Associates 14 L.P. | 7,961,912 12.9% | -3,941,160 (-33.11%) | View |
| 2020-04-17 5:26 pm Purchase | 13D | MERSANA THERAPEUTICS INC MRSN | Bain Capital Life Sciences Fund II L.P. | 3,071,566 5.2% | 3,071,566 (New Position) | View |
| 2020-02-14 4:40 pm Sale | 13G | MERSANA THERAPEUTICS INC MRSN | ArrowMark Colorado Holdings LLC | 0 0% | -2,027,505 (Position Closed) | View |
| 2020-02-14 2:41 pm Sale | 13G | MERSANA THERAPEUTICS INC MRSN | BIOTECHNOLOGY VALUE FUND L P | 3,755,553 7.4% | -1,170,866 (-23.77%) | View |
| 2020-02-07 08:45 am Purchase | 13G | MERSANA THERAPEUTICS INC MRSN | BlackRock Inc. BLK | 2,465,319 5.1% | 2,465,319 (New Position) | View |
| 2019-12-20 8:22 pm Purchase | 13G | MERSANA THERAPEUTICS INC MRSN | Venrock Healthcare Capital Partners II L.P. | 2,483,903 5.2% | 2,483,903 (New Position) | View |
| 2019-10-09 5:30 pm Purchase | 13G | MERSANA THERAPEUTICS INC MRSN | BIOTECHNOLOGY VALUE FUND L P | 4,926,419 10.3% | 2,426,419 (+97.06%) | View |